Dabur India Limited Stock

Equities

DABUR

INE016A01026

Personal Products

Market Closed - NSE India S.E. 07:43:47 2024-04-18 am EDT 5-day change 1st Jan Change
503.8 INR -0.01% Intraday chart for Dabur India Limited -0.47% -9.57%
Sales 2024 * 125B 1.49B Sales 2025 * 138B 1.65B Capitalization 893B 10.69B
Net income 2024 * 18.89B 226M Net income 2025 * 21.68B 260M EV / Sales 2024 * 6.67 x
Net cash position 2024 * 60.73B 727M Net cash position 2025 * 69.48B 832M EV / Sales 2025 * 5.97 x
P/E ratio 2024 *
46.7 x
P/E ratio 2025 *
40.8 x
Employees 5,319
Yield 2024 *
1.22%
Yield 2025 *
1.4%
Free-Float 32.31%
More Fundamentals * Assessed data
Dynamic Chart
India's Godrej Consumer says operating conditions remain subdued, Africa sales sting RE
India's Marico forecasts revenue growth in Q4 after three quarters of fall, shares up RE
Indian Equities Gain as Investors Await Central Bank's Policy Decision MT
Dabur India flags sluggish demand in March-quarter; shares drop RE
Dabur India Expects Mid Single-Digit Growth in Fiscal Q4 Consolidated Revenue; Shares Drop Nearly 4% MT
Analysis-In India's sizzling stock market, consumer stocks rise 18% but are laggards RE
Dabur India Limited Announces Resignation of Sushil Chandra as Non-Executive Independent Director and Ceases as Member of the Audit Committee, Corporate Social Responsibility Committee and Risk Management Committee CI
Indian consumer goods sector slows; rural shows recovery signs - NielsenIQ RE
Nomura Adjusts Dabur India's Price Target to INR675 From INR685, Keeps at Buy MT
Jefferies Adjusts Dabur India’s Price Target to INR660 From INR650, Keeps at Buy MT
Dabur India Records Rise in Fiscal Q3 Consolidated Net Profit MT
Transcript : Dabur India Limited, Q3 2024 Earnings Call, Jan 31, 2024
Dabur India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Colgate-Palmolive India posts Q3 profit jump on lower expenses, urban demand RE
Dabur Expects Mid to High Single-Digit Growth in Fiscal Q3 Consolidated Revenue MT
More news
1 day+0.29%
1 week+0.95%
Current month-3.40%
1 month-3.49%
3 months-6.32%
6 months-5.37%
Current year-9.31%
More quotes
1 week
489.20
Extreme 489.2
507.65
1 month
489.20
Extreme 489.2
532.55
Current year
489.20
Extreme 489.2
575.50
1 year
489.20
Extreme 489.2
597.10
3 years
482.25
Extreme 482.25
658.95
5 years
357.55
Extreme 357.55
658.95
10 years
176.60
Extreme 176.6
658.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 93-12-31
Director of Finance/CFO 49 -
Chief Operating Officer - 22-08-31
Members of the board TitleAgeSince
Chairman 55 07-07-22
Director/Board Member 54 01-10-31
Director/Board Member 47 12-01-30
More insiders
Date Price Change Volume
24-04-18 503.8 -0.01% 2 604 037
24-04-16 503.9 +1.76% 2,928,056
24-04-15 495.2 -1.08% 3,600,795
24-04-12 500.6 -1.12% 4,166,549
24-04-10 506.2 +0.62% 1,978,008

Delayed Quote NSE India S.E., April 18, 2024 at 01:54 am EDT

More quotes
Dabur India Limited is a fast-moving consumer goods (FMCG) company. Its segments include Consumer care business, Food business, Retail business and Other segments. Its Consumer care business segment includes home care, personal care, and health care. Its Food business segment includes juices, beverages, and culinary. Its Retail business segment includes retail stores. Its Other segments include Guar gum, pharma and others. Its product categories include hair care, oral care, health care, skin care, home care and Energizers, Ethicals. Its FMCG portfolio includes eight brands, including Dabur Chyawanprash, Dabur Honey, Dabur PudinHara, Dabur Lal Tail and Dabur Honitus in the healthcare space; Dabur Amla and Dabur Red Paste in the personal care category, and Real in the food and Beverage’s category. In addition, Vatika is an international brand. Its products include Real Juices, Dabur Red Paste, Odonil, Odomos, Dabur Hommade Tasty Masala, Rheumatil Oil, Dabur Badam Oil, and Odopic.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
40
Last Close Price
503.9 INR
Average target price
602 INR
Spread / Average Target
+19.47%
Consensus